%0 Journal Article
%T Evaluation of ColdZyme Mouth Spray against Common Cold in Preschool Staff
%A Mats Clarsund
%J Open Journal of Respiratory Diseases
%P 136-140
%@ 2163-9418
%D 2017
%I Scientific Research Publishing
%R 10.4236/ojrd.2017.74014
%X <div style=\"text-align:justify;\">
	The common cold is one of the most frequently encountered infectious diseases
in humans and, despite the modest severity in most cases; it presents a
significant economic burden upon society and individuals. ColdZyme<sup>&reg;</sup> Mouth
Spray (ColdZyme<sup>&reg;</sup>, Enzymatica AB, Lund, Sweden) is a mouth spray intended
to reduce the probability of catching a cold and can also help shorten the duration
of a cold if used at an early stage of the infection, by forming a barrier
on the oropharyngeal mucous membrane. This study evaluated the effect of
ColdZyme<sup>&reg;</sup> on common cold related sick-leave in preschool (kindergarten)
staff. Fifteen preschool staff members were evaluated over a 6-month period
and ColdZyme<sup>&reg;</sup> was used according to instructions. Sick-leave days were recorded
and compared to historical data. The number of average sick leave days
decreased during the period from 7.4 days to 4.1 days (<i>p</i> = 0.04). It is notable
that, if occurring, the majority of subjects perceived a common cold infection
as milder than usual. Conclusion: Using ColdZyme<sup>&reg;</sup> to apply a barrier to the
pharyngeal mucous membrane may be an easy and practical way to prevent or
reduce infections and corresponding sick leave in personnel from the preschool
environment.
</div>
%K Common Cold
%K Preschool
%K ColdZyme&amp
%K reg
%K Mouth Spray
%U http://www.scirp.org/journal/PaperInformation.aspx?PaperID=79637